AstraZeneca said on Tuesday it had submitted a request with US health regulators to grant emergency use authorisation for a new treatment to prevent Covid-19.
The British drugmaker had said in August that the treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any Covid-19 symptoms by 77 per cent in a late-stage trial.
(Published 05 October 2021, 07:31 IST)
JOIN US